15th
January 2019 - The
global hemodialysis Concentrates market is anticipated to grow over the
forecast period and the trend is projected to witness the same trend in future.
An increasing number of end stage chronic disease patients and patient suffering
from hypertension & diabetes are the essential driving factors for the
growth of hemodialysis Concentrates market. Emerging trends including
increasing venture funding and private investments to support the manufacturing
of advanced products along with increasing government spending on healthcare
for end stage renal diseases treatment are the potential factors that may
significantly propel the hemodialysis Concentrates market over the next seven
years. Additionally, low preference by the patients for kidney transplantation
coupled with the technological advancements to support hemodialysis
concentrates is estimated to fuel the demand for industry.
Browse
Full Research Report @ https://www.millioninsights.com/industry-reports/hemodialysis-concentrates-market
Major challenge for the industry is the low awareness of kidney diseases
among people. Treatment modalities coupled with product recalls and decrease in
Medicare reimbursements to the dialysis centers are the essential factors that
may hinder the hemodialysis concentrate market.The global hemodialysis &
peritoneal dialysis market is segmented into two segments namely peritoneal
dialysis and hemodialysis including services & products. The segment of
hemodialysis accounted for a higher market share of the market. The peritoneal
dialysis segment is anticipated to grow a high CAGR over the forecast period.
The market for hemodialysis includes consumables, services, and machines. On
the basis modality, the hemodialysis Concentrates market is divided into short
daily hemodialysis, nocturnal and conventional hemodialysis.
The market for hemodialysis comprises of water treatment systems and is
subdivided into portable water disinfection system and central water
disinfection system. the peritoneal dialysis market comprises of concentrates,
transfer sets, peritoneal dialysis services, dialysates, catheters, and
machines. By the type of modality, the market is characterized into ambulatory
peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD).
Additionally, the global dialysis market is characterized on the basis
end users into home dialysis and in center dialysis. The in center dialysis
market comprise of hospitals, independent center for dialysis. Home dialysis
market includes home hemodialysis and peritoneal dialysis. Geography wise the
hemodialysis concentrates market is segment is segmented into global comprising
of North America (Canada and U.S), Asia Pacific (India, Japan, and Rest of
Asia-Pacific), Europe (Germany, U.K, and France), Rest of the world (Latin
America, Africa, and the Middle East) and China.
North American region held a sizeable market share in the hemodialysis
concentrate market which was followed by Asia Pacific, Europe and rest of the
world. The Asia-Pacific region is expected to dominate the market over the
forecast period specifically in China owing to the increasing number of
patients with renal diseases, increasing number of dialysis centers, rising
number of government initiatives to modify and develop dialysis facilities,
increasing awareness among people about new dialysis treatment modalities and
high number of ESRD patient population base.
Notable players in the hemodialysis concentrate market include B. Braun
Melsungen AG (Germany), DaVita Healthcare Partners, Inc. (U.S.), Fresenius
Medical Care AG & Co. KGaA (Germany), Nipro Corporation (Japan), Baxter
International, Inc. (U.S.), Diaverum Deutschland GmbH (Germany), NxStage
Medical, Inc. (U.S.)., and Nikkiso Co. Ltd. (Japan).
Request
a Free Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/hemodialysis-concentrates-market/request-sample
Comments
Post a Comment